PsyAccess
Spravato®Registry-verifiedDesignated-centers model

Emergis

Kloetinge, Netherlands

Treatment & access

About this provider

Emergis, the mental health institution for Zeeland, has treated people with treatment-resistant depression with esketamine nasal spray at its dedicated esketamine outpatient clinic in Kloetinge since January 2024, so patients from Zeeland no longer need to travel to Tilburg or the Randstad. The treatment is reimbursed care under strict conditions: prior psychotherapy and at least three medication treatments must have had insufficient effect. The programme is structured in three phases within a six-month course. Clients administer the spray themselves; temporary side effects such as dizziness, headache and raised blood pressure peak and subside after roughly 40 to 50 minutes, and clients only go home once everything is stable. Emergis participates in the national ENC-NL network researching long-term effects.

Services & programs

  • Esketamine nasal spray treatment for treatment-resistant depression at the esketamine outpatient clinic (since January 2024)
  • Broad ambulatory and clinical mental health care for Zeeland, including acute mental health care

Common questions

Who qualifies for esketamine treatment at Emergis?

The treatment falls within reimbursed care but only under strict conditions: previous psychotherapy and at least three medication treatments must have failed to give sufficient effect.

What happens during a session?

Clients spray the medication into the nose themselves. Side effects such as dizziness, headache and increased blood pressure often occur, peaking and subsiding after about 40 to 50 minutes. Clients may only go home once everything is stable.

How long does the treatment take?

The treatment is structured in three phases within a six-month course; in practice clients sometimes need more time than planned in the protocol.

Where does the treatment take place?

At the Emergis esketamine outpatient clinic in Kloetinge (Zeeland).

Looking at alternatives? Esketamine nasal spray treatment is offered by specialised centres across the Netherlands affiliated with the national Esketamine Nasal Spray Consortium (ENC-NL), of which Emergis is a member.

Verification

This record was taken directly from an official registry or program list and is re-checked on a rolling cadence.

Spotted an error? See our methodology for how records are checked and how to report a correction.